Tenax Therapeutics (TENX) Enterprise Value Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.97% |
| Dec 31, 2025 | -258.13% |
| Sep 30, 2025 | -196.65% |
| Jun 30, 2025 | -144.34% |
| Mar 31, 2025 | -237.46% |
| Dec 31, 2024 | -157.06% |
| Sep 30, 2024 | -127.46% |
| Jun 30, 2024 | -62.61% |
| Mar 31, 2024 | -46.01% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -8.56% |
| Jun 30, 2023 | -43.28% |
| Mar 31, 2023 | -43.71% |
| Dec 31, 2022 | 26.73% |
| Sep 30, 2022 | 18.87% |
| Jun 30, 2022 | 6.73% |
| Mar 31, 2022 | 35.53% |
| Dec 31, 2021 | 24.28% |
| Sep 30, 2021 | -19.82% |
| Jun 30, 2021 | 30.16% |
| Mar 31, 2021 | 15.23% |
| Dec 31, 2020 | 4.58% |
| Sep 30, 2020 | -0.67% |
| Jun 30, 2020 | 19.71% |
| Mar 31, 2020 | 27.07% |
| Dec 31, 2019 | 25.92% |
| Sep 30, 2019 | 1.59% |
| Jun 30, 2019 | 3.62% |
| Mar 31, 2019 | -49.15% |
| Dec 31, 2018 | 13.95% |
| Sep 30, 2018 | -15.94% |
| Jun 30, 2018 | 1.42% |
| Apr 30, 2015 | -61.55% |
| Apr 30, 2014 | -294.22% |